A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Ripretinib
- DRUG: Sunitinib
Sponsor
Deciphera Pharmaceuticals, LLC